IDO expression by dendritic cells: tolerance and tryptophan catabolism
- PMID: 15459668
- DOI: 10.1038/nri1457
IDO expression by dendritic cells: tolerance and tryptophan catabolism
Abstract
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.
Comment in
-
Literature watch: implications for transplantation. AHR and tryptophan catabolism: putting the effector T-cell response to sleep.Am J Transplant. 2012 Apr;12(4):801. doi: 10.1111/j.1600-6143.2012.04058.x. Am J Transplant. 2012. PMID: 22458381 No abstract available.
Similar articles
-
Molecules in focus: indoleamine 2,3-dioxygenase.Int J Biochem Cell Biol. 2007;39(12):2167-72. doi: 10.1016/j.biocel.2007.01.004. Epub 2007 Jan 20. Int J Biochem Cell Biol. 2007. PMID: 17320464 Review.
-
Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.Methods Mol Biol. 2011;677:269-80. doi: 10.1007/978-1-60761-869-0_19. Methods Mol Biol. 2011. PMID: 20941617
-
Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.Semin Immunol. 2001 Aug;13(4):213-8. doi: 10.1006/smim.2000.0317. Semin Immunol. 2001. PMID: 11437628 Review.
-
[A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].Bull Mem Acad R Med Belg. 2003;158(7-9):356-63; discussion 364-5. Bull Mem Acad R Med Belg. 2003. PMID: 15132006 French.
-
Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.Transpl Int. 2005 Jan;18(1):95-100. doi: 10.1111/j.1432-2277.2004.00031.x. Transpl Int. 2005. PMID: 15612990
Cited by
-
How mesenchymal stem cells interact with tissue immune responses.Trends Immunol. 2012 Mar;33(3):136-43. doi: 10.1016/j.it.2011.11.004. Epub 2012 Jan 7. Trends Immunol. 2012. PMID: 22227317 Free PMC article. Review.
-
Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases.Clin Dev Immunol. 2012;2012:941346. doi: 10.1155/2012/941346. Epub 2011 Oct 27. Clin Dev Immunol. 2012. PMID: 22110541 Free PMC article. Review.
-
Up-Regulation of Immune Checkpoints in the Thymus of PRRSV-1-Infected Piglets in a Virulence-Dependent Fashion.Front Immunol. 2021 May 11;12:671743. doi: 10.3389/fimmu.2021.671743. eCollection 2021. Front Immunol. 2021. PMID: 34046040 Free PMC article.
-
CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk.Int Immunopharmacol. 2013 Mar;15(3):638-45. doi: 10.1016/j.intimp.2013.02.007. Epub 2013 Feb 20. Int Immunopharmacol. 2013. PMID: 23434857 Free PMC article.
-
Monitoring regulatory immune responses in tumor immunotherapy clinical trials.Front Oncol. 2013 May 6;3:109. doi: 10.3389/fonc.2013.00109. eCollection 2013. Front Oncol. 2013. PMID: 23653893 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials